{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:27:00Z","timestamp":1776396420692,"version":"3.51.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00059-023-05182-6","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T15:01:56Z","timestamp":1684335716000},"page":"195-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SARS-CoV-2, vaccination or autoimmunity as causes of cardiac inflammation. Which form prevails?","SARS-CoV-2, Impfung oder Autoimmunit\u00e4t als Ursachen f\u00fcr Herzentz\u00fcndungen. Welche Form \u00fcberwiegt?"],"prefix":"10.1007","volume":"48","author":[{"given":"Bernhard","family":"Maisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"issue":"15","key":"5182_CR1","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMra0800028","volume":"360","author":"LT Cooper","year":"2009","unstructured":"Cooper\u00a0LT (2009) Myocarditis. N\u00a0Engl J Med 360(15):1526\u20131538. https:\/\/doi.org\/10.1056\/NEJMra0800028","journal-title":"N Engl J Med"},{"key":"5182_CR2","first-page":"3","volume":"1","author":"HT Aretz","year":"1987","unstructured":"Aretz\u00a0HT, Billingham\u00a0ME, Edwards\u00a0WD et\u00a0al (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1:3\u201314","journal-title":"Am J Cardiovasc Pathol"},{"key":"5182_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson\u00a0P, McKenna\u00a0W, Bristow\u00a0M et\u00a0al (1996) Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841\u2013842","journal-title":"Circulation"},{"key":"5182_CR4","first-page":"3","volume":"4","author":"B Maisch","year":"1999","unstructured":"Maisch\u00a0B, B\u00fcltmann\u00a0B, Factor\u00a0S et\u00a0al (1999) World Heart Federation consensus conferences\u2019s definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat 4:3\u20134","journal-title":"Heartbeat"},{"key":"5182_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11897-014-0196-6","volume":"11","author":"B Maisch","year":"2014","unstructured":"Maisch\u00a0B, Ruppert\u00a0V, Pankuweit\u00a0S (2014) Management of fulminant myocarditis: a\u00a0diagnosis in search of its etiology but with therapeutic options. Curr Heart Fail Rep 11:166\u2013177. https:\/\/doi.org\/10.1007\/s11897-014-0196-6","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"5182_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00059-020-04909-z","volume":"45","author":"C Chen","year":"2020","unstructured":"Chen\u00a0C, Zhou\u00a0Y, Wang\u00a0DW (2020) SARS-CoV-2: a\u00a0potential novel etiology of fulinant myocarditis. Herz 45(3):230\u2013232. https:\/\/doi.org\/10.1007\/s00059-020-04909-z","journal-title":"Herz"},{"key":"5182_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00059-020-04929-9","volume":"45","author":"B Maisch","year":"2020","unstructured":"Maisch\u00a0B, D\u00f6rr\u00a0R (2020) COVID-19\u2014What we know and what we need to know: There are more questions than answers. Herz 45:311\u2013312","journal-title":"Herz"},{"key":"5182_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00059-020-04932-0","volume":"45","author":"A Stang","year":"2020","unstructured":"Stang\u00a0A, Standl\u00a0F, J\u00f6ckel\u00a0K\u2011H (2020) Characteristics of COVID-19 pandemic and public health health consequences. Herz 45:313\u2013315. https:\/\/doi.org\/10.1007\/s00059-020-04932-0","journal-title":"Herz"},{"key":"5182_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00059-020-04928-2","volume":"45","author":"AK Gitt","year":"2020","unstructured":"Gitt\u00a0AK, Bernhardt\u00a0A, Zahn\u00a0R et al (2020) The COVID-19 Registry in Rhineland-Palatinate in the context of international registry activities documenting COVID-19 outcomes. Herz 45:316\u2013318. https:\/\/doi.org\/10.1007\/s00059-020-04928-2","journal-title":"Herz"},{"key":"5182_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.10007\/s00059-020-04922-2","volume":"45","author":"R D\u00f6rr","year":"2020","unstructured":"D\u00f6rr\u00a0R (2020) Protecting patients and healthcare personnel from COVID-19: considerations for practice and outpatient care in cardiology. Herz 45:319\u2013320. https:\/\/doi.org\/10.10007\/s00059-020-04922-2","journal-title":"Herz"},{"key":"5182_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00059-020-04925-z","volume":"45","author":"B Maisch","year":"2020","unstructured":"Maisch\u00a0B (2020) SARS-CoV\u20112 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS? Herz 45:321\u2013322. https:\/\/doi.org\/10.1007\/s00059-020-04925-z","journal-title":"Herz"},{"key":"5182_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00059-020-04920-4","volume":"45","author":"T Kessler","year":"2020","unstructured":"Kessler\u00a0T, Schunkert\u00a0H (2020) Inhibitors of the renin-angiotensin system and SARS-CoV\u20112 infection. Herz 45:323\u2013324. https:\/\/doi.org\/10.1007\/s00059-020-04920-4","journal-title":"Herz"},{"key":"5182_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00059-020-04924-0","volume":"45","author":"K-H Kuck","year":"2020","unstructured":"Kuck\u00a0K\u2011H (2020) Arrhythmias and sudden cardiac death in the COVID-19 pandemic. Herz 45:325\u2013326. https:\/\/doi.org\/10.1007\/s00059-020-04924-0","journal-title":"Herz"},{"key":"5182_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00059-020-04931-1","volume":"45","author":"H Thiele","year":"2020","unstructured":"Thiele\u00a0H (2020) Cardiovascular emergencies in the COVID-19 pandemic. Herz 45:327\u2013328. https:\/\/doi.org\/10.1007\/s00059-020-04931-1","journal-title":"Herz"},{"key":"5182_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00059-020-04923-1","volume":"45","author":"S M\u00f6hlenkamp","year":"2020","unstructured":"M\u00f6hlenkamp\u00a0S, Thiele\u00a0H (2020) Ventilation of COVID-19 patients in intensive care-units. Herz 45:329\u2013331. https:\/\/doi.org\/10.1007\/s00059-020-04923-1","journal-title":"Herz"},{"key":"5182_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00059-020-04927-x","volume":"45","author":"J Ge","year":"2020","unstructured":"Ge\u00a0J (2020) Extracorporeal membrane oxygenation in the treatment of respiratory failure during COVID-19. Herz 45:332\u2013333. https:\/\/doi.org\/10.1007\/s00059-020-04927-x","journal-title":"Herz"},{"issue":"11","key":"5182_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/eurheartj\/ehab696","volume":"43","author":"The Task Force for the management of COVID-19 of the European Society of Cardiology","year":"2022","unstructured":"The Task Force for the management of COVID-19 of the European Society of Cardiology (2022) European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic:part1\u2014Epidemiology, pathophysiology,and diagnosis. Eur Heart\u00a0J 43(11):1033\u20131058. https:\/\/doi.org\/10.1093\/eurheartj\/ehab696","journal-title":"Eur Heart J"},{"issue":"11","key":"5182_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/eurheartj\/ehab697","volume":"43","author":"Task Force for the management of COVID-19 of the European Society of Cardiology","year":"2022","unstructured":"Task Force for the management of COVID-19 of the European Society of Cardiology (2022) ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2\u2011care pathways, treatment, and follow-up. Eur Heart\u00a0J 43(11):1059\u20131103. https:\/\/doi.org\/10.1093\/eurheartj\/ehab697","journal-title":"Eur Heart J"},{"key":"5182_CR19","volume-title":"Neues Coronavirus (SARSCoV-2) \u2013 Informationen f\u00fcr die haus\u00e4rztliche Praxis. AWMF-Register-Nr.\u00a0053-054, 6. Version","author":"H Blankenfeld","year":"2020","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemeinmedizin (DEGAM), Blankenfeld\u00a0H, Kaduszkiewicz\u00a0H, Kochen\u00a0MM et al (2020) Neues Coronavirus (SARSCoV-2) \u2013 Informationen f\u00fcr die haus\u00e4rztliche Praxis. AWMF-Register-Nr.\u00a0053-054, 6. Version (www.degam-leitlinien.de)"},{"issue":"23","key":"5182_CR20","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120.047349","volume":"141","author":"NS Hendren","year":"2020","unstructured":"Hendren\u00a0NS, Drazner\u00a0MH, Bozkurt\u00a0B, Cooper\u00a0LT Jr (2020) Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 141(23):1903\u20131914. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047349","journal-title":"Circulation"},{"issue":"1","key":"5182_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00059-020-05006-x","volume":"46","author":"B Maisch","year":"2021","unstructured":"Maisch\u00a0B (2021) The ESC recommendations for COVID-19-no guideline, but a\u00a0learning guidance. Herz 46(1):46\u201355. https:\/\/doi.org\/10.1007\/s00059-020-05006-x","journal-title":"Herz"},{"key":"5182_CR22","unstructured":"https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Fallzahlen.html. Accessed 15 Mar 2023"},{"key":"5182_CR23","unstructured":"https:\/\/de.statista.com\/themen\/6018\/corona. Accessed 16 Mar 2023"},{"issue":"3","key":"5182_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jacc.2020.11.031","volume":"77","author":"R Kawakami","year":"2021","unstructured":"Kawakami\u00a0R, Sakamoto\u00a0A, Kawai\u00a0K et al (2021) Pathological evidence for SARS-CoV\u20112 as a\u00a0cause of myocarditis: JACC review topic of the week. J\u00a0Am Coll Cardiol 77(3):314\u2013325. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.031","journal-title":"J Am Coll Cardiol"},{"key":"5182_CR25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0046-8177(87)80363-5","volume":"18","author":"HT Aretz","year":"1987","unstructured":"Aretz\u00a0HT (1987) Myocarditis: the Dallas criteria. Hum Pathol 18:619\u2013624","journal-title":"Hum Pathol"},{"issue":"3","key":"5182_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s000590050007","volume":"25","author":"B Maisch","year":"2000","unstructured":"Maisch\u00a0B, Portig\u00a0I, Ristic\u00a0A et\u00a0al (2000) Definition of inflammatory cardiomyopathy(Myocarditis): On the way to consensus. A status report. Herz 25(3):200\u2013209","journal-title":"Herz"},{"key":"5182_CR27","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"AL Caforio","year":"2013","unstructured":"Caforio\u00a0AL, Pankuweit\u00a0S, Arbustini\u00a0E et\u00a0al (2013) Current state of knowledge on aetiology, diagnosis, management an therapy of myocarditis: a\u00a0position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart\u00a0J 34:2636\u20132648","journal-title":"Eur Heart J"},{"key":"5182_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00059-020-04900-8","volume":"45","author":"B Maisch","year":"2020","unstructured":"Maisch\u00a0B, Pankuweit\u00a0S (2020) Inflammatory dilated cardiomyopathy. Etiology and clinical management. Herz 45:221\u2013229","journal-title":"Herz"},{"key":"5182_CR29","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","volume":"31","author":"S Sala","year":"2020","unstructured":"Sala\u00a0S, Peretto\u00a0G, Gramegna\u00a0M et al (2020) Acute myocarditis presenting as a\u00a0reverse Tako-Tsubo syndrome in a\u00a0patient with SARS-CoV2 respiratory infection. Eur Heart 31:1861\u20131862","journal-title":"Eur Heart"},{"key":"5182_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ejhf.1828","volume":"22","author":"G Tavazzi","year":"2020","unstructured":"Tavazzi\u00a0G, Pellegrini\u00a0C, Mauretti\u00a0M et al (2020) Myocardial localiization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 22:911\u2013915","journal-title":"Eur J Heart Fail"},{"key":"5182_CR31","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/ehf2.12805","volume":"7","author":"F Escher","year":"2020","unstructured":"Escher\u00a0F, Pietsch\u00a0H, Aleshcheva\u00a0G et al (2020) Detection of viral SARS-CoV\u20112 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail 7:2440\u20132442","journal-title":"ESC Heart Fail"},{"key":"5182_CR32","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/cvr\/cvaa160","volume":"115","author":"P Wenzel","year":"2020","unstructured":"Wenzel\u00a0P, Kopp\u00a0S, Gobel\u00a0S et al (2020) Evidence of SARS-CoV\u20112 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab. Cardiovasc Res 115:1661\u20131663","journal-title":"Cardiovasc Res"},{"key":"5182_CR33","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1093\/eurheartj\/ehaa664","volume":"41","author":"C Basso","year":"2020","unstructured":"Basso\u00a0C, Leone\u00a0O, Rizo\u00a0S et al (2020) Pathological features of COVID-19 associated myocardial injury: a\u00a0multicentre cardiovascular pathology study. Eur Heart\u00a0J 41:3827\u20133835","journal-title":"Eur Heart J"},{"key":"5182_CR34","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.120.049465","volume":"142","author":"SE Fox","year":"2020","unstructured":"Fox\u00a0SE, Li\u00a0G, Akmatbekov\u00a0A et al (2020) Unexpected features of cardiac pathology in COVID-19 infection. Circulation 142:1123\u20131125","journal-title":"Circulation"},{"issue":"11","key":"5182_CR35","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann\u00a0VO, Careri\u00a0L, Wieters\u00a0I et al (2020) Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(11):1265\u20131273. https:\/\/doi.org\/10.1001\/jamacardio.2020.3557","journal-title":"JAMA Cardiol"},{"key":"5182_CR36","doi-asserted-by":"publisher","first-page":"107300","DOI":"10.1016\/j.carpath.2020.107300","volume":"50","author":"MK Halushka","year":"2021","unstructured":"Halushka\u00a0MK, Vander Heide\u00a0RS (2021) Myocarditis is rare in COVID-19 autopsies: Cardiovascular findings across 277 post-mortem examinations. Cardiovasc Pathol 50:107300","journal-title":"Cardiovasc Pathol"},{"key":"5182_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.056817","volume":"145","author":"E Ammirati","year":"2022","unstructured":"Ammirati\u00a0E, Lupi\u00a0L, Palazzini\u00a0M et al (2022) Prevalence, characteristics, and outcomes of COVID-19\u2013associated acute myocarditis. Circulation 145:1123\u20131139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056817","journal-title":"Circulation"},{"issue":"14","key":"5182_CR38","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/cvr\/cvaa267","volume":"116","author":"D Bojkova","year":"2020","unstructured":"Bojkova\u00a0D, Wagner\u00a0JUG, Shumliakivska\u00a0M et al (2020) SARS-CoV\u20112 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res 116(14):2207\u20132215. https:\/\/doi.org\/10.1093\/cvr\/cvaa267","journal-title":"Cardiovasc Res"},{"key":"5182_CR39","first-page":"1843","volume":"323","author":"W Wang","year":"2020","unstructured":"Wang\u00a0W, Xu\u00a0Y, Gao\u00a0R et al (2020) Detection of SARS-CoV\u20112 in different types of clinical specimens. JAMA 323:1843\u20131844","journal-title":"JAMA"},{"issue":"2","key":"5182_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann\u00a0M, Kleine-Weber\u00a0H, Schroeder\u00a0S et al (2020) SARS-CoV\u20112 cell entry depends on ACE2 and TMPRSS2 and is blocked by a\u00a0clinically proven protease inhibitor. Cell 181(2):271\u2013280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"5182_CR41","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.3390\/cells9112508","volume":"9","author":"A Magadum","year":"2020","unstructured":"Magadum\u00a0A, Kishore\u00a0R (2020) Cardiovascular manifestations of COVID-19 infection. Cells 9:2508. https:\/\/doi.org\/10.3390\/cells9112508","journal-title":"Cells"},{"key":"5182_CR42","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.3390\/ijms24065374","volume":"24","author":"P Pannucci","year":"2023","unstructured":"Pannucci\u00a0P, Jefferson\u00a0SR, Hampshire\u00a0J et al (2023) COVID-19-induced myocarditis: Pathophysiological roles of ACE2 and toll-like receptors. Int J Mol Sci 24:5374. https:\/\/doi.org\/10.3390\/ijms24065374","journal-title":"Int J Mol Sci"},{"key":"5182_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.737257","author":"R Tanacli","year":"2021","unstructured":"Tanacli\u00a0R, Doeblin\u00a0P, G\u00f6tze\u00a0C et al (2021) Covid-19 vs. classical myocarditis associated myocardial injury evaluated by cardiac magnetic resonance and endomyocardial biopsy. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.737257","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"5182_CR44","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/clc.23886","volume":"45","author":"O Blagova","year":"2022","unstructured":"Blagova\u00a0O, Lutokhina\u00a0Y, Kogan\u00a0E et al (2022) Chronic biopsy proven post-COVID myoendocarditis with SARS-Cov\u20112 persistence and high level of antiheart antibodies. Clin Cardiol 45(9):952\u2013959. https:\/\/doi.org\/10.1002\/clc.23886","journal-title":"Clin Cardiol"},{"key":"5182_CR45","doi-asserted-by":"publisher","unstructured":"Lloyd Dini F, Baldini U, Bytyci I et al (2023) Acute pericarditis as a major clinical manifestation of Long COVID-19 syndrome. Int J Cardiol 374:129\u2013134. https:\/\/doi.org\/10.1016\/j.ijcard.2022.12.019","DOI":"10.1016\/j.ijcard.2022.12.019"},{"issue":"3","key":"5182_CR46","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/clc.23978","volume":"46","author":"O Blagova","year":"2023","unstructured":"Blagova\u00a0O, Yuliya\u00a0L, Savina\u00a0P (2023) Corticosteroids are effective in the treatment of viruspositive post-COVID myoendocarditis with high autoimmune activity. Clin Cardiol 46(3):352\u2013354. https:\/\/doi.org\/10.1002\/clc.23978","journal-title":"Clin Cardiol"},{"key":"5182_CR47","unstructured":"Deutsches Zentrum f\u00fcr Infektionsforschung (DZIF) Klinische Studien. https:\/\/clinicalsite.org\/~dzif\/de\/cat\/2084. Zugegriffen: 21.03.2023"},{"key":"5182_CR48","doi-asserted-by":"publisher","first-page":"e000373","DOI":"10.1136\/bmjmed-2022-000373","volume":"2","author":"A Husby","year":"2023","unstructured":"Husby\u00a0A, Gulseth\u00a0HL, Hovi\u00a0P et al (2023) Clinical outcomes of myocarditis after SARS-CoV\u20112 mRNA vaccination in four Nordic countries: Population based cohort study. BMJMED 2:e373. https:\/\/doi.org\/10.1136\/bmjmed-2022-000373","journal-title":"BMJMED"},{"key":"5182_CR49","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","volume":"385","author":"D Mevorach","year":"2021","unstructured":"Mevorach\u00a0D, Anis\u00a0E, Cedar\u00a0N et al (2021) Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N\u00a0Engl J Med 385:2140\u20132149. https:\/\/doi.org\/10.1056\/NEJMoa2109730","journal-title":"N Engl J Med"},{"issue":"6","key":"5182_CR50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.121.055913","volume":"144","author":"KF Larson","year":"2021","unstructured":"Larson\u00a0KF, Ammirati\u00a0E, Adler\u00a0ED et al (2021) Myocarditis after BNT162b2 and mRNA-1273 vaccination. Circulation 144(6):506\u2013508","journal-title":"Circulation"},{"key":"5182_CR51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13443","author":"GA Diaz","year":"2021","unstructured":"Diaz\u00a0GA, Parsons\u00a0GT, Gering\u00a0SK et al (2021) Myocarditis and pericarditis after vaccination for COVID-19. JAMA. https:\/\/doi.org\/10.1001\/jama.2021.13443","journal-title":"JAMA"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-023-05182-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-023-05182-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-023-05182-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:03:53Z","timestamp":1686733433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-023-05182-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5182"],"URL":"https:\/\/doi.org\/10.1007\/s00059-023-05182-6","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"3 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.\u00a0Maisch declares that he has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}